Check out your Company Bowl for anonymous work chats.
We are taking a number of steps to scale up manufacturing operations at risk to accelerate our ability to supply a potential novel vaccine for COVID-19, subject to the vaccine demonstrating effectiveness and gaining approval. Learn more here:
Read on to see how RNA vaccines differ from conventional vaccines.
#ScienceWillWin because of scientists like Dr. Annaliesa and many others across our industry who are working on potential breakthroughs for patients. #COVID19 #Coronavirus
How are Vaccines developed? Learn more here.
We are all #InItTogether. Learn more about one of the ways we help patients access their Pfizer medicines – today and every day. #PfizerProud
When faced with a new opponent, science doesn’t back down. It revs up. We are all #InItTogether and, together, we will work to beat this thing. #ScienceWillWin
Lidia Fonseca, Chief Digital and Technology Officer, and her team are working behind the scenes to ensure our researchers & scientists have the tools they need to find a potential treatment for #COVID19. Find out more from Fast Company.
In the race to develop treatments for #COVID19, we’re working with a compound that was initially identified to treat #SARS. See why our scientists think that the fastest way to find a treatment isn’t to start from scratch, but use something that already exists. #DrugDevelopment #Pharmaceuticals #Coronavirus
Susan Silbermann, our Global President of Emerging Markets, shares how she’s seen our colleagues respond to the #COVID19 pandemic. #InItTogether #WorldHealthDay
Know More: Vice President and Chief Scientific Officer of Viral Vaccines, Phil Dormitzer, discusses COVID19 vaccine research and recovery.
